Structure of human des(1-45) factor Xa at 2.2 A resolution
- PMID:8355279
- DOI: 10.1006/jmbi.1993.1441
Structure of human des(1-45) factor Xa at 2.2 A resolution
Abstract
The structure of a large molecular fragment of factor Xa that lacks only a Gla (gamma-carboxyglutamic acid) domain (N-terminal 45 residues) has been solved by X-ray crystallography and refined at 2.2 A resolution to a crystallographic R-value of 0.168. The fragment identity was clearly established by automated Edman degradation. X-ray structure analysis confirmed the biochemical characterization and also revealed that the N-terminal epidermal growth factor (EGF)-like domain is flexibly disordered in crystals. The second EGF module, however, is positionally ordered making contacts with the catalytic domain. The overall folding of the catalytic domain is similar to that of alpha-thrombin, excluding the insertion loops of the latter with respect to simpler serine proteinases. The C-terminal arginine of the A-chain interacts in a substrate-like manner with the S1 specificity site of the active site of a crystallographically neighboring molecule. Based on this interaction and the structure of D-PheProArg methylene-thrombin, a model of the commonly used dansylGluGlyArg methylene inhibitor-factor Xa interaction is proposed. The region of factor Xa corresponding to the fibrinogen recognition site of thrombin has a reversed electrical polarity to the anion binding fibrinogen recognition site of thrombin but possesses a site similar to the Ca2+ binding site of trypsin and other serine proteinases. The structure of the C-terminal EGF domain of factor Xa is the first to be determined crystallographically. Its folding has been comprehensively compared with similar domains determined by NMR. Although the A-chain makes 44 contacts at less than 3.5 A with the catalytic domain, only 16 involve the EGF module. In addition, the A-chain makes 30 intermolecular contacts with a neighboring catalytic domain.
Similar articles
- Energetics of thrombin-thrombomodulin interaction.Vindigni A, White CE, Komives EA, Di Cera E.Vindigni A, et al.Biochemistry. 1997 Jun 3;36(22):6674-81. doi: 10.1021/bi962766a.Biochemistry. 1997.PMID:9184147
- Solution structure of the N-terminal EGF-like domain from human factor VII.Muranyi A, Finn BE, Gippert GP, Forsén S, Stenflo J, Drakenberg T.Muranyi A, et al.Biochemistry. 1998 Jul 28;37(30):10605-15. doi: 10.1021/bi980522f.Biochemistry. 1998.PMID:9692950
- The relative orientation of Gla and EGF domains in coagulation factor X is altered by Ca2+ binding to the first EGF domain. A combined NMR-small angle X-ray scattering study.Sunnerhagen M, Olah GA, Stenflo J, Forsén S, Drakenberg T, Trewhella J.Sunnerhagen M, et al.Biochemistry. 1996 Sep 10;35(36):11547-59. doi: 10.1021/bi960633j.Biochemistry. 1996.PMID:8794734
- Contributions of Gla and EGF-like domains to the function of vitamin K-dependent coagulation factors.Stenflo J.Stenflo J.Crit Rev Eukaryot Gene Expr. 1999;9(1):59-88.Crit Rev Eukaryot Gene Expr. 1999.PMID:10200912Review.
- Molecular Interactions of Thrombin.Tulinsky A.Tulinsky A.Semin Thromb Hemost. 1996;22(2):117-24. doi: 10.1055/s-2007-998998.Semin Thromb Hemost. 1996.PMID:8807707Review.
Cited by
- Thrombolysis by chemically modified coagulation factor Xa.Pryzdial EL, Meixner SC, Talbot K, Eltringham-Smith LJ, Baylis JR, Lee FM, Kastrup CJ, Sheffield WP.Pryzdial EL, et al.J Thromb Haemost. 2016 Sep;14(9):1844-54. doi: 10.1111/jth.13402. Epub 2016 Aug 17.J Thromb Haemost. 2016.PMID:27359348Free PMC article.
- An anticoagulant RNA aptamer that inhibits proteinase-cofactor interactions within prothrombinase.Buddai SK, Layzer JM, Lu G, Rusconi CP, Sullenger BA, Monroe DM, Krishnaswamy S.Buddai SK, et al.J Biol Chem. 2010 Feb 19;285(8):5212-23. doi: 10.1074/jbc.M109.049833. Epub 2009 Dec 18.J Biol Chem. 2010.PMID:20022942Free PMC article.
- Evaluation of proposed modes of binding of (2S)-2-[4-[[(3S)-1-acetimidoyl-3-pyrrolidinyl]oxy]phenyl]-3-(7-am idino- 2- naphthyl)propanoic acid hydrochloride and some analogs to factor Xa using a comparative molecular field analysis.Vaz RJ, McLean LR, Pelton JT.Vaz RJ, et al.J Comput Aided Mol Des. 1998 Mar;12(2):99-110. doi: 10.1023/a:1007969517376.J Comput Aided Mol Des. 1998.PMID:9690170
- Oral anticoagulants for Asian patients with atrial fibrillation.Sabir I, Khavandi K, Brownrigg J, Camm AJ.Sabir I, et al.Nat Rev Cardiol. 2014 May;11(5):290-303. doi: 10.1038/nrcardio.2014.22. Epub 2014 Mar 11.Nat Rev Cardiol. 2014.PMID:24614113Review.
- Structural basis for chemical inhibition of human blood coagulation factor Xa.Kamata K, Kawamoto H, Honma T, Iwama T, Kim SH.Kamata K, et al.Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6630-5. doi: 10.1073/pnas.95.12.6630.Proc Natl Acad Sci U S A. 1998.PMID:9618463Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous